These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 532636)
1. [Antiarrhythmic effect of 4-(3',5'-bis ((n-pyrrolidinyl) methyl)-4'-hydroxyanilino) quinazoline (changrolin) on aconitine-induced arrhythmia in rats (author's transl)]. Wang ZM; Zhang YF; Ding GS Yao Xue Xue Bao; 1979 Jul; 14(7):408-11. PubMed ID: 532636 [No Abstract] [Full Text] [Related]
2. Studies on a new antiarrhythmic drug changrolin-4-(3',5'-bis [(N-pyrrolidinyl) methyl]-4'-hydroxyanilino)-quinazoline. Li LQ; Qu ZX; Wang ZM; Zeng YL; Ding GS; Hu GJ; Yang XY Sci Sin; 1979 Oct; 22(10):1220-8. PubMed ID: 515728 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of antiarrhythmic effects of intravenous injections of changrolin and BL-4712A(author's transl)]. Wang CG; Wang ZM; Zhang YF; Ding GS Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):29-31. PubMed ID: 6211899 [No Abstract] [Full Text] [Related]
4. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine. Bartosova L; Novak F; Bebarova M; Frydrych M; Brunclik V; Opatrilova R; Kolevska J; Mokry P; Kollar P; Strnadova V; Suchy P Eur J Pharmacol; 2007 Dec; 575(1-3):127-33. PubMed ID: 17706639 [TBL] [Abstract][Full Text] [Related]
8. Effect of a new ultrashort betalytic agent on aconitine-induced arrhythmia. Bartosová L; Novák F; Frydrych M; Parák T; Opatrilová R; Brunclík V; Kolevská J; El Moataz E; Necas J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):339-43. PubMed ID: 16601784 [TBL] [Abstract][Full Text] [Related]
9. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias]. Maĭmeskulova LA; Maslov LN Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172 [TBL] [Abstract][Full Text] [Related]
11. [Experimental studies on antiarrhythmic effect of jumi extraction]. Xu C; Ye TM; Zhu L; Chen YY; Shen YL Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 Nov; 23(4):399-402. PubMed ID: 21180116 [TBL] [Abstract][Full Text] [Related]
12. [Antiarrhythmic effects of crebanine]. Yu ZP; Mu YS; Zhao ZX; Wang FC Zhongguo Zhong Yao Za Zhi; 1992 Nov; 17(11):685-7, 704. PubMed ID: 1301759 [TBL] [Abstract][Full Text] [Related]
13. [The effects of infusion rate of Changrolin on drug concentration in blood and ECG (author's transl)]. Qu ZX; Cao CY; Zhuang YH Yao Xue Xue Bao; 1980 Aug; 15(8):449-55. PubMed ID: 7211388 [No Abstract] [Full Text] [Related]
14. [Antiarrhythmic properties of afobazole and other 2-mercaptobensimidazole derivatives]. Turilova AI; Mozhaeva TIa Eksp Klin Farmakol; 2010 May; 73(5):8-11. PubMed ID: 20597362 [TBL] [Abstract][Full Text] [Related]
15. [Anti-arrhythmic effect of changrolin combined with nicotinamide in experimental arrhythmia]. Gu CG; Chen WZ; Dong YL; Ding GS Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):173-7. PubMed ID: 6239508 [No Abstract] [Full Text] [Related]
16. [Comparative study of the antiarrhythmic activity of L-, D-and DL-stereoisomers of potassium magnesium aspartate]. Spasov AA; Iezhitsa IN; Zhuravleva NV; Gurova NA; Sinolitskiĭ MK; Voronin SP Eksp Klin Farmakol; 2007; 70(1):17-21. PubMed ID: 17402586 [TBL] [Abstract][Full Text] [Related]
17. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent]. Denisenko PP; Vinogradova TV; Semenov AA Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605 [TBL] [Abstract][Full Text] [Related]